Rongyang Li

5PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 13, 2026
Histone Variant H2A.Z2 Hyper-Transcription Induced by E2F1 Accelerates Lung Adenocarcinoma Progression via the JAK-STAT Signaling Pathway.

|Jan 09, 2026
RECQL4 promotes the malignant progression of lung adenocarcinoma through the YBX1/G3BP1-mediated NF-κB signaling pathway.

Rongyang Li, Wenhao Yu, Dingxin Wang

|Apr 03, 2023
EIF4A3 Acts on the PI3K-AKT-ERK1/2-P70S6K Pathway through FLOT1 to Influence the Development of Lung Adenocarcinoma.

Wenhao Yu, Jinghui Liang, Tao Fang

|Jan 08, 2023
Nomograms Combining PHI and PI-RADS in Detecting Prostate Cancer: A Multicenter Prospective Study.

Yongheng Zhou, Qiang Fu, Zhiqiang Shao

|Dec 11, 2022
Effects of Neoadjuvant Radiotherapy on Survival in Patients with Stage IIIA-N2 Non-Small-Cell Lung Cancer Following Pneumonectomy.

Chenghao Qu, Rongyang Li, Jingyi Han

Pageof 1

Frequent Collaborators

2 joint publications

Hui Tian

1 joint publications

Chenghao Qu

1 joint publications

Wenhao Yu

1 joint publications

Jinghui Liang